MediciGlobal

It did not take long for the National Cancer Institute in the U.S. to take action to address patient recruitment for cancer trials…

“The nation’s most important system for judging the clinical effectiveness of cancer treatments is approaching “a state of crisis.” That is the disturbing verdict of experts assembled by the National Academy of Sciences to review the performance of clinical trials sponsored by the National Cancer Institute (NCI).

Unless the shortcomings are remedied, some of President Obama’s ambitious health care reforms will be jeopardized and his audacious goal of finding “a cure for cancer in our time” will have almost no chance at all.” Read the editorial in the New York Times on April 24, 2010.

http://www.nytimes.com/2010/04/25/opinion/25sun1.html?scp=1&sq=faltering%20cancer%20trials&st=cse

Now, with public and congressional scrutiny on the National Cancer Institute for failing to recruit and complete cancer trials, the Institute launched a new online resource for clinical trials professionals and the cancer community. It is the first step in many the NCI needs to take, and it’s a step in the right direction.

Check out AccrualNet at http://accrualnet.cancer.gov